Page 79 - Sohini Das

Bharat Biotech had agreed to offer vaccine at reasonable rates to Govt: MoH

ICMR has spent Rs 35 cr on Covaxin clinical trials

What is the controversy surrounding Serum Institute's Covishield and EMA?

The vaccine did not make it to the European regulator's approved list, although it has been approved by WHO and also the UK MHRA

Serum Institute partners with RDIF to make 300 mn doses of Sputnik V

RDIF says SII can make combination doses of Astra-Sputnik in future

Oximeters, BP machines to get cheaper as NPPA caps trade margins at 70%

Earlier margins were as high as 709% for some devices; revised prices will come into effect from July 20

Abbott's Korea-imported PanBio Covid-19 self test launched at Rs 325

Firm expects demand from both, institutions and retail consumers, will import kits in 4-pack sizes from Korean plant; Test linked with NAVICA app which uploads results on ICMR website

Urge people to use pvt channel vaccine availability: NITI Aayog's V K Paul

Says overall vaccine distribution is done systematically as per availability with manufacturers; 'visibility' on how many doses are expected ahead is shared with state govts

Hetero seeks emergency use authorisation for Merck's antiviral drug

Clinical trial shows molnupiravir helps in early recovery in non-hospitalised Covid-19 patients

Sanofi-GSK Covid-19 vaccine gets nod to start phase-3 trials in India

India part of 35,000 volunteer global efficacy trial

Cabinet reshuffle: Harsh Vardhan fails to clear test ahead of third wave

India's management of the second wave of the Covid-19 pandemic drew all-round criticism both within the country and outside.

4 million doses of Pfizer, Moderna likely through COVAX by August

Indemnity issue to be settled to bring the two US vaccines through COVAX

7.5 mn need 2nd jab in July; we have 4.8 mn doses: Rajasthan minister

In a Q&A, the state's Health Minister Raghu Sharma says Rajasthan has started work to ensure no shortage of medical oxygen during the third Covid-19 wave

Covid-19 cases low but health ministry warns against 'revenge travel'

80% of new cases from 90 districts; N-E states show high case positivity rate

Seven-day average Covid-19 vaccinations at half of June 21 record

Shortage and staggered supplies seem to be playing dampener against ensuring consistent vaccination rates.

80% new Covid cases in India being reported from 90 districts, says govt

Health Ministry cautions against rising travel to tourist spots; 73 districts still reporting over 10% positivity rate; north-eastern states vulnerable

Bharat Biotech-Brazil row: Covaxin nod under controlled conditions

The agency said the suspension - which put the EUA application on ice - was due to missing data from the vaccine's clinical trials

CoWIN goes global: India makes tech open source, 142 nations show interest

This is perhaps the first time any nation is making a software platform developed by its public sector initiative open for the world

Serum Institute may double production of AstraZeneca-Oxford vaccine in 2022

Expect 200-million AstraZeneca vaccine doses next year

Covaxin 77.8% effective against symptomatic Covid-19: Bharat Biotech

The company claimed Covaxin is the first to report promising efficacy against asymptomatic infections based on qPCR testing that will help in reducing disease transmission

NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine

These are scheduled drugs (or ones that are under price control) and low priced

Covovax denied trials on children; no nod needed for Sputnik Light

The decision comes as a setback to SII, which had sought permission to start a pediatric clinical trial of Covovax